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OBJECTIVE: The end-tidal concentration of inhalation anesthetics is a clinical indicator for predicting the
emergence from anesthesia. This study was conducted to assess the relationship between arterial blood and
end-tidal sevoflurane concentrations during emergence.
METHODS: Thirty-two female American Society of Anesthesiologists physical status I-II patients receiving
general anesthesia for elective gynecologic surgery were included. A fixed dose of 3.5% inspiratory sevoflurane
in 6 L min-1 oxygen was maintained until the end of surgery. At 20 and 10 minutes before and 0, 5, 10, 15, and
20 minutes after discontinuing sevoflurane, as well as at the time of eye opening by verbal command, defined
as awakening, 1 ml arterial blood was obtained to measure its sevoflurane concentration by gas
chromatography. Simultaneous inspiratory and end-tidal concentrations of sevoflurane were detected by an
infrared analyzer and tested by Bland–Altman agreement analysis.
RESULTS: The arterial blood concentrations of sevoflurane were similar to the simultaneous end-tidal
concentrations during emergence: 0.36% (0.10) and 0.36% (0.08) sevoflurane at awakening, respectively. The
mean time from discontinuing sevoflurane to eye opening was 15.8 minutes (SD 2.9, range 10-26) and was
significantly correlated with the duration of anesthesia (52-192 minutes) (P=0.006) but not with the body mass
index or total fentanyl dose.
CONCLUSION: The mean awakening arterial blood concentration of sevoflurane was 0.36%. The time to
awakening was prolonged in accordance with the anesthetic duration within 3 hours. With well-assisted
ventilation during emergence, the sevoflurane end-tidal concentration was nearly equal to its arterial blood
concentration, which could be a feasible predictor for awakening.
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& INTRODUCTION
Sevoflurane, with its properties of a lower blood-gas
partition coefficient of 0.69 (1) and a less irritating odor,
allows for rapid and smooth anesthetic induction (2,3) and
less coughing during emergence (4). However, with a higher
fat-blood partition coefficient of 47.5 (5), the extubation time
with sevoflurane is prolonged up to 20-25% compared with
desflurane (6). In addition, emergence and airway reflex
recovery may be delayed by a greater body mass index (7).
During the elimination phase, sevoflurane washout
progresses from the brain and body to the alveolar
space and can be detected by the end-tidal concentration.
Clinically, the end-tidal concentration of inhalation anes-
thetics has been a feasible indicator for predicting the
emergence from general anesthesia, especially after des-
flurane anesthesia (8). However, irregular respiration before
awakening usually results in fluctuations of the end-tidal
concentrations of inhalation anesthetics. Alternatively, the
arterial blood concentration provides a steadier and closer
representation of the brain concentration during uptake
(9-13) and recognizes the time-dependent elimination of
inhaled anesthetics from the brain and blood to the alveolar
cavity (14-16). Our previous study (10) revealed no further
uptake of sevoflurane into the brain after 40 minutes but
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near-constant uptake into the body until the end of
the study (60 minutes). Thus, we hypothesized that
sevoflurane would accumulate in the body and/or blood
during an increased anesthetic duration and that this
accumulation could be verified by analyzing the arterial
blood concentrations during emergence and the time to
awakening. The aims of this study were to examine
the arterial blood concentrations of sevoflurane during
emergence and the effect of the anesthetic duration, as well
as the validity of non-invasively measuring the end-tidal
concentration to assess the simultaneous arterial blood
concentration.
& MATERIALS AND METHODS
Patients
After obtaining IRB approval (TSGHIRB-097-05-189) and
written informed consent, 32 20-60-year-old ASA I or
II gynecologic patients undergoing elective surgery were
included. Those patients with severe cardiopulmonary
diseases, hepatic diseases (17), or neuropathy or who were
receiving regular hypnotics or sedatives were excluded.
Anesthetic Management
In the operating room, after the administration of 100 mcg
intravenous fentanyl and 0.5 ml subcutaneous 2% lidocaine,
a 20-gauge catheter was placed into the radial artery for
blood sampling and perioperative blood pressure monitor-
ing. General anesthesia was induced with 1.5 mg kg-1
propofol and 1.5 mg kg-1 succinylcholine for endotracheal
intubation and was maintained with 0.1 mg kg-1 cisatracur-
ium and fixed 3.5% inspiratory sevoflurane in 6 L min-1
oxygen throughout the entire procedure. Nitrous oxide
was not used. To suppress the patient’s painful responses
beyond the ability of sevoflurane alone, 25 or 50 mcg
fentanyl was titrated. An Ohmeda-Datex anesthetic machine
was used with soda lime (CO2 absorber), and the minute
ventilation was adjusted to keep the end-tidal CO2 between
38-42 mmHg. The leakage of each system was assessed by
using constant-pressure ventilation with a test lung. The
sampled gases (approximately 210 ml min-1) were redir-
ected into the circuit. Both the inspiratory and end-tidal
sevoflurane concentrations were detected by an infrared
multi-gas analyzer (Datex AS/5 Anesthesia system; Datex,
Helsinki, Finland), calibrated according to the manufac-
turer’s recommendations. A Finometer (FMS, Finapres
Measurement Systems, Arnhem, Netherlands) was used to
assess cardiac output. Hypotension, defined as a decrease in
blood pressure by 25% from baseline, was treated with
intravenous fluid and/or ephedrine (5 mg bolus). After the
operation was completed, we turned off the vaporizer and
then intravenously administered 2 mg neostigmine and
0.4 mg glycopyrrolate to reverse the neuromuscular block-
ade. The end-tidal CO2 was maintained between 38
and 42 mmHg with manually assisted ventilation in quiet
conditions without any other stimulation during sevoflur-
ane elimination. Awakening was defined as eye opening to
verbal command and was tested every 30 seconds after
discontinuing sevoflurane until the appropriate response
was observed. Extubation was accomplished after brief
endotracheal suction. The time from the discontinuation of
sevoflurane to awakening and the duration of anesthesia
were recorded. The inspiratory and end-tidal sevoflurane
concentrations, end-tidal CO2, blood pressure, heart rate,
Table 1 - Patient characteristics (N=32).
Characteristics Mean (SD) Range Median
Age, years 40.3 (8.1) 24-53 40
Weight, kg 58.2 (8.8) 40-76 58
Height, cm 158.7 (5.5) 148-167 160
Body mass index, kg m-2 23.1 (3.2) 17.7-29.3 22.8
Fentanyl, mcg kg-1 2.2 (0.6) 1.3-4.0 2.0
Duration, min 109.5 (35.1) 52-192 113.5
Time to eye opening, min 15.8 (2.9) 10-26 15.0
Table 2 - The arterial blood, inspiratory and end-tidal concentrations of sevoflurane after the discontinuation of
sevoflurane during emergence from general anesthesia in gynecologic patients (N=32).
Time (min) -20 -10 0 5 10 15 Eye Opening 20
Arterial concentration 2.15 (0.23) 2.12 (0.22) 2.09 (0.19) 0.71 (0.13) 0.53 (0.13) 0.38 (0.11) 0.36 (0.10) 0.27 (0.10)
Inspiratory concentration 3.49 (0.11) 3.50 (0.06) 3.49 (0.05) 0.02 (0.06) 0.01 (0.03)
End-tidal concentration 2.99 (0.12) 3.02 (0.13) 3.01 (0.11) 0.70 (0.14) 0.52 (0.11) 0.39 (0.08) 0.36 (0.08) 0.29 (0.06)
Values are presented as the mean (SD). The mean time to eye opening was 15.8 (2.9) min.
The time point 0 min was immediately prior to the discontinuation of 3.5% sevoflurane.
Table 3 - Hemodynamic and ventilatory variables during emergence (N=32).
Time (min) -20 -10 0 5 10 15 Eye Opening 20*
HR 73 (9.7) 76 (10.6) 76 (11.3) 84 (13.7) 86 (13.7) 87 (13.4) 92 (13.7) 83 (9.0)
MAP 81.8 (16.0) 79.8 (14.9) 77.7 (17.2) 95.3 (18.4) 103.6 (19.7) 104.1 (23.1) 103.8 (23.8) 100.1 (17.2)
CO 4.6 (1.3) 4.7 (1.2) 4.8 (1.0) 5.4 (1.6) 5.4 (1.7) 5.1 (1.7) 5.1 (1.5) 6.2 (1.8)
CI 2.9 (0.7) 3.0 (0.7) 3.1 (0.6) 3.4 (1.0) 3.4 (1.0) 3.2 (1.1) 3.2 (0.9) 3.8 (1.0)
TPR 1542 (426) 1493 (411) 1433 (417) 1773 (842) 1814 (661) 2048 (910) 2009 (834) 1728 (638)
ETCO2 40.8 (7.2) 40.1 (1.9) 39.6 (1.7) 39.6 (2.4) 40.1 (2.3) 39.7 (2.0) 39.6 (3.9) 40.5 (2.9)
Values are presented as the mean (SD). The mean time to eye opening was 15.8 (2.9) min.
HR, heart rate; MAP, mean arterial blood pressure; CO, cardiac output; CI, cardiac index; TPR, total peripheral resistance; ETCO2, end-tidal CO2.
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and body temperature were recorded every 30 seconds
using commercial software until 20 minutes after stopping
sevoflurane.
Determination of Sevoflurane Blood
Concentrations
Before induction, 10 ml of each patient’s arterial blood
without sevoflurane was collected to calculate the blood/
gas partition coefficient (l) of sevoflurane for each patient
(13). Sevoflurane in each blood sample was converted to the
corresponding concentration based on gas chromatographic
measurements and the blood/gas partition coefficient of
sevoflurane (l) measured in each patient.
Gas Chromatography Conditions
The HP 6890 series GC system (Hewlett-Packard,
Wilmington, DE) comprised a headspace sampler (Agilent
G1888), an oven, a flame-ionization detector and an
integrator. The oven temperature was set at 40 C˚, increased
to 200 C˚ at a rate of 25 C˚ per minute and maintained at this
level for 2.60 min. Both the injection and detection tempera-
tures were set at 250 C˚. The inlet pressure was set at 349 kPa.
Injection was performed in the direct injection mode. The
carrier gas (helium) flow was 25.0 ml min-1. Separation was
achieved with a capillary column (HP-5; 30.0 m6 0.32 mm
ID, 0.25-mm film thickness; Restek, Bellefonte, PA). An
integrator and a data acquisition system were provided by
Agilent CHEMOSTATION software. The method used to
create a calibration curve for measuring the blood sevoflur-
ane concentration was modified according to our previous
publication (13). The mean (SD) of the blood/gas partition
coefficient of sevoflurane (l) for 32 patients was 0.65 (0.01).
Statistical Analysis
The mean, range and median (time to eye opening) were
used to describe the patients’ characteristics. Clinical para-
meters were presented as the mean (SD) over time. Bivariate
relationships between variables were analyzed by simple
linear regressions and Pearson’s correlations. Moreover, we
used the Bland–Altman agreement analysis to determine the
degree of agreement between the simultaneous arterial blood
and end-tidal sevoflurane concentrations at three time points
relative to awakening using MedCalcH statistical software
(Version 12.2.1.0). A P value ,0.05 was considered statisti-
cally significant.
& RESULTS
The demographic data are summarized in Table 1. The
mean time from discontinuing sevoflurane to eye opening
by verbal command was 15.8 minutes (2.9) (range 10-26,
median 15), with a 95% confidence interval of 14.5-16.6 min.
Table 2 shows the arterial blood, inspiratory and end-tidal
concentrations of sevoflurane before and during emergence.
The mean arterial and end-tidal concentrations were 2.09%
(0.19) and 3.01% (0.11) before discontinuing and decreased
to 0.36% (0.10) and 0.36% (0.08) at awakening, respectively.
The end-tidal concentrations decreased more prominently
in the initial 5 minutes after discontinuation and then
remained nearly equal to the arterial concentrations until
awakening. The end-tidal CO2 concentrations were kept
steady during emergence, whereas the cardiac output and
cardiac index increased by less than 15% after discontinuing
sevoflurane, without significant differences (Table 3).
As shown in Figure 1, the arterial concentrations, as well
as the awakening end-tidal concentrations, before disconti-
nuing sevoflurane and at awakening were not significantly
Figure 1 - The correlation between the duration of anesthesia
and the arterial concentrations of sevoflurane before disconti-
nuation and at awakening. The arterial concentrations just prior
to discontinuing 3.5% sevoflurane (upper) and at awakening
(middle), as well as the awakening end-tidal concentration
(lower), were not correlated with the anesthetic duration (52-
192 minutes) (P=0.323, 0.520 and 0.880, respectively), indicating
both saturated blood contents and fast alveolar washout of
sevoflurane.
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correlated with the duration of general anesthesia (P= 0.162,
0.277 and 0.295, respectively).
The Bland-Altman plot (Figure 2) displays the differences
between the arterial concentration and end-tidal concentra-
tion at awakening. The differences between the two concen-
trations ranged from -0.15 to 0.18%, with a mean (SD) of
0.01% (0.09). After grouping, the differences fell into the
acceptable range (¡1.96 SD), regardless of the length of the
awakening time.
Figure 3 depicts that the time to awakening was
prolonged according to the duration of anesthesia from 52
to 192 minutes (P= 0.006) but was not correlated with the
body mass index (range 18-29) or the total fentanyl dose
(P= 0.971 and 0.850, respectively).
& DISCUSSION
This study first quantitatively demonstrated that the
awakening arterial blood concentration of sevoflurane was
0.36% (0.10) in surgical gynecologic patients. An increased
duration of sevoflurane anesthesia within 3 hours did not
elevate the arterial concentration before discontinuing
sevoflurane but did prolong the awakening time. With
well-assisted ventilation, the end-tidal concentration of
sevoflurane was nearly equal to the arterial concentration
and could be a reliable predictor for eye opening during the
emergence from general anesthesia.
The total body uptake and elimination of inhaled
anesthetics should be proportional to the duration of
general anesthesia (18,19). Compared with desflurane, the
higher blood-gas and tissue-blood partition coefficients of
sevoflurane theoretically increase total body uptake and
detain elimination in patients with a longer anesthetic
duration and higher body mass index (7,20). Mckay et al. (7)
demonstrated that the time from anesthetic discontinuation
to the first response to verbal command and the time to
recover the ability to swallow after sevoflurane exceeded
those after desflurane. In addition, the contribution of the
body mass index to this delay of airway reflex recovery was
more pronounced after sevoflurane anesthesia. Sevoflurane
has been clearly proven to prolong the extubation time
compared with desflurane (20-25%) (6) but to reduce the
mean extubation time by 13% relative to isoflurane (21). In
our study, the arterial concentration before discontinuing
sevoflurane was not correlated with the duration of
anesthesia (55-192 min), indicating that a limited content
of sevoflurane was present in the blood (lower blood-gas
partition coefficient, 0.65). However, the time to awakening
was proportionally prolonged by a longer duration of
anesthesia, further indicating increased body uptake (higher
muscle-blood and fat-blood partition coefficients, 3.1 and
47.5, respectively) (5). By measuring arterial blood concen-
trations during the emergence period, this study provided
convincing evidence for sevoflurane elimination that should
be taken into consideration in cases of a prolonged duration
of anesthesia.
The rate of uptake of inhaled anesthetics depends on the
alveolar concentration and ventilation (22-25), blood solubi-
lity (5) and cardiac output (22). Similarly, sevoflurane
washout commences from the brain and body via the
circulating blood into the alveolar space during elimination,
allowing the lungs to ventilate it into the air. When the brain
or arterial concentration decreases to a certain level, the
patient awakens enough to follow the verbal command for
eye opening. In this study, the end-tidal concentrations of
sevoflurane decreased more prominently in the initial 5
minutes after discontinuation, indicating a rapid alveolar
washout, and then became consistently close to the arterial
concentrations. Our previous study demonstrated that the
end-tidal concentrations of desflurane are generally lower
than the arterial blood concentrations during elimination in
gynecologic patients (8); this effect is related to the lower
blood-gas partition coefficient of 0.42 and tissue/blood
partition coefficients of desflurane (5). By determining the
arterial blood concentration, we therefore identified that the
end-tidal concentration of sevoflurane, which is close to
0.36%, is a reliable indicator for predicting emergence from
general anesthesia.
Figure 2 - The Bland-Altman plot displays the differences between the arterial and end-tidal concentrations at awakening plotted
against the average of the two concentrations. The differences ranged from -0.15 to 0.18, all of which were within the SD range of
¡1.96. The two methods may be used interchangeably.
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There are two limitations in the current study. First, all of
our patients were female, had BMIs less than 29 and
received a maximum 3-hour duration of anesthesia. The
minimum alveolar concentration (MAC) value of sevoflur-
ane varied from 2.6% in young adults (age 18-35 yrs) to
1.58% to 2.05% in middle-aged adults (age 16-59 yrs), to
1.45% in elderly people (age over 70 yrs) (1). The MAC-
awake of sevoflurane in children ranged from 0.43 to 0.66%
(26), whereas the awakening time was significantly shorter
in male patients than in females (27). In our study, the
relatively lean body size and shorter duration of general
anesthesia may not demonstrate the BMI effect of sevo-
flurane compared with previous studies (7,20). The clinical
inference should be adjusted for the patient’s characteristics.
Second, the minute ventilation could hardly be controlled
by a ventilator after the reversal of spontaneous breathing
during emergence. We therefore manually assisted the
ventilation to keep the end-tidal CO2 concentrations as
close to 38-42 mmHg as possible before extubation. The
end-tidal CO2 depicts the status of minute ventilation and
cardiac output. Hyperventilation may decrease the PaCO2
and cerebral blood flow and then depress cardiac output,
which reverses and decelerates the elimination of inhaled
anesthetics. In our study, the minute ventilation and cardiac
index of all patients was kept steady before extubation,
which revealed a good agreement between the awakening
arterial blood and end-tidal sevoflurane concentrations. By
investigating both arterial blood and end-tidal concentra-
tions, the clinical influence of minute ventilation and cardiac
output can be further clarified during the elimination of
inhaled anesthetics.
In conclusion, we have demonstrated the awakening
arterial concentration of sevoflurane in gynecologic patients.
An increased duration of sevoflurane anesthesia (1-3 hours)
did not significantly elevate arterial concentrations before
discontinuation and at awakening but did prolong the time to
awakening, indicating limited blood uptake but increased
body uptake of sevoflurane. With well-assisted ventilation
during emergence, the end-tidal concentration of sevoflurane
can be a reliable indicator for predicting awakening from
general anesthesia.
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